HK1209325A1 - Attenuated swine influenza vaccines and methods of making and use thereof - Google Patents

Attenuated swine influenza vaccines and methods of making and use thereof

Info

Publication number
HK1209325A1
HK1209325A1 HK15110019.9A HK15110019A HK1209325A1 HK 1209325 A1 HK1209325 A1 HK 1209325A1 HK 15110019 A HK15110019 A HK 15110019A HK 1209325 A1 HK1209325 A1 HK 1209325A1
Authority
HK
Hong Kong
Prior art keywords
making
methods
influenza vaccines
swine influenza
attenuated swine
Prior art date
Application number
HK15110019.9A
Other languages
English (en)
Chinese (zh)
Inventor
M Hause Benjamin
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of HK1209325A1 publication Critical patent/HK1209325A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HK15110019.9A 2012-07-17 2015-10-14 Attenuated swine influenza vaccines and methods of making and use thereof HK1209325A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261672398P 2012-07-17 2012-07-17
PCT/US2013/050000 WO2014014726A1 (en) 2012-07-17 2013-07-11 Attenuated swine influenza vaccines and methods of making and use thereof

Publications (1)

Publication Number Publication Date
HK1209325A1 true HK1209325A1 (en) 2016-04-01

Family

ID=48874529

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110019.9A HK1209325A1 (en) 2012-07-17 2015-10-14 Attenuated swine influenza vaccines and methods of making and use thereof

Country Status (20)

Country Link
US (2) US9216211B2 (ko)
EP (1) EP2874656B1 (ko)
JP (1) JP6467672B2 (ko)
KR (1) KR102027758B1 (ko)
CN (1) CN104582725B (ko)
AU (2) AU2013290597B2 (ko)
BR (1) BR112015001020B1 (ko)
CA (1) CA2879228C (ko)
DK (1) DK2874656T3 (ko)
EA (1) EA033027B1 (ko)
ES (1) ES2662022T3 (ko)
HK (1) HK1209325A1 (ko)
HU (1) HUE036110T2 (ko)
MX (1) MX365880B (ko)
MY (1) MY166879A (ko)
NZ (2) NZ704188A (ko)
PH (1) PH12015500095A1 (ko)
PL (1) PL2874656T3 (ko)
PT (1) PT2874656T (ko)
WO (1) WO2014014726A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2879228C (en) * 2012-07-17 2021-07-13 Merial Limited Attenuated swine influenza vaccines and methods of making and use thereof
CN108601824A (zh) * 2015-12-28 2018-09-28 梅里亚股份有限公司 M Hyo多价疫苗及其用途
EP3548078A1 (en) * 2016-11-30 2019-10-09 Boehringer Ingelheim Animal Health USA Inc. Attenuated swine influenza vaccines and methods of making and use thereof
CN106939355A (zh) * 2017-03-01 2017-07-11 苏州系统医学研究所 一种流感病毒弱毒活疫苗毒株的筛选和鉴定方法
CN107064499B (zh) * 2017-03-15 2019-06-18 青岛蔚蓝生物制品有限公司 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138854B1 (en) 1983-03-08 1992-11-04 Chiron Mimotopes Pty. Ltd. Antigenically active amino acid sequences
US5585250A (en) 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
ATE292980T1 (de) 1996-10-11 2005-04-15 Univ California Immunostimulierende oligonucleotidekonjugate
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
WO2005028658A2 (en) 2003-05-28 2005-03-31 Wisconsin Alumni Research Foundation Recombinant influenza vectors with a polii promoter and ribozymes
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
US8673613B2 (en) * 2007-06-18 2014-03-18 Medimmune, Llc Influenza B viruses having alterations in the hemaglutinin polypeptide
JP2011513235A (ja) 2008-02-21 2011-04-28 バイオロジカル ミメティクス インコーポレイテッド 免疫原性インフルエンザ組成物
US20140004149A1 (en) * 2010-01-24 2014-01-02 Biological Mimetics, Inc. Immunogenic Influenza Composition
CA2879228C (en) * 2012-07-17 2021-07-13 Merial Limited Attenuated swine influenza vaccines and methods of making and use thereof

Also Published As

Publication number Publication date
KR102027758B1 (ko) 2019-10-02
US20140023681A1 (en) 2014-01-23
EP2874656B1 (en) 2017-12-06
CA2879228C (en) 2021-07-13
NZ712713A (en) 2017-05-26
JP2015524266A (ja) 2015-08-24
BR112015001020B1 (pt) 2022-04-19
AU2013290597B2 (en) 2016-02-04
AU2016202693A1 (en) 2016-05-19
MX2015000713A (es) 2015-10-12
PH12015500095B1 (en) 2015-03-02
EA033027B1 (ru) 2019-08-30
US9216211B2 (en) 2015-12-22
WO2014014726A1 (en) 2014-01-23
JP6467672B2 (ja) 2019-02-13
MY166879A (en) 2018-07-24
BR112015001020A2 (ko) 2017-08-15
KR20150036685A (ko) 2015-04-07
CA2879228A1 (en) 2014-01-23
NZ704188A (en) 2016-04-29
PL2874656T3 (pl) 2018-04-30
PH12015500095A1 (en) 2015-03-02
AU2016202693B2 (en) 2017-11-16
ES2662022T3 (es) 2018-04-05
US9623105B2 (en) 2017-04-18
HUE036110T2 (hu) 2018-06-28
CN104582725B (zh) 2017-06-23
AU2013290597A1 (en) 2015-02-19
MX365880B (es) 2019-06-18
US20160120973A1 (en) 2016-05-05
CN104582725A (zh) 2015-04-29
DK2874656T3 (en) 2018-01-15
PT2874656T (pt) 2018-03-09
EA201500140A1 (ru) 2016-02-29
EP2874656A1 (en) 2015-05-27

Similar Documents

Publication Publication Date Title
IL261204A (en) Influenza virus vaccines and their use
HK1211206A1 (en) Virus-containing formulation and use thereof
IL237159A0 (en) Pyrazol-4-yl-heterocyclyl-carboxamide cyclic ether compounds and methods of use
HK1209646A1 (en) Nasal influenza vaccine composition
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
HK1225645A1 (zh) Pcv2b趨異株疫苗組合物以及使用方法
HK1203834A1 (en) Attenuated streptococcus suis vaccines and methods of making and use thereof
EP2897639A4 (en) IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE
HK1221641A1 (zh) 疫苗組合物及使用方法
IL236270A0 (en) Cationic lipid vaccine compositions and methods of use
EP3022298A4 (en) WAXED INFLUENZA VACCINE AND USES THEREOF
EP2852397A4 (en) HUWENTOXIN IV VARIANTS AND METHODS OF USE
IL244354B (en) Flu vaccine and treatment
HK1220656A1 (zh) 減弱的流感病毒和疫苗
HK1209325A1 (en) Attenuated swine influenza vaccines and methods of making and use thereof
EP2988778A4 (en) CLOSTRIDIUM DIFFICILE IMPREGENT AND METHOD OF USE
HK1258694A1 (zh) 減毒溶血曼海姆氏菌疫苗及其製造和用途
EP2906576A4 (en) GLYCOSPHINGOLIPIDES AND METHOD OF USE THEREOF
HK1201283A1 (en) Influenza c virus and vaccine
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
EP2950818A4 (en) TUMORIN VEGETABLES AND METHOD FOR USE THEREOF